All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practice: Madrid coinfection registry findings - Berenguer, Juan; Gil‐Martin, Ángela; Jarrin, Inmaculada; Moreno, Ana; Dominguez, Lourdes; Montes, Marisa; Aldámiz‐Echevarría, Teresa; Téllez, María J.; Santos, Ignacio; Benitez, Laura; Sanz, José; Ryan, Pablo; et al. (Hepatology (Baltimore, Md.), 2018)
Keywords: Administration, Oral; Antiviral agents; Antiviral Agents - therapeutic use; Antiviral drugs; CD4 antigen; Cirrhosis; Coinfection; Confidence intervals; Female; Genotypes; Health risk assessment; Hepacivirus - genetics; Hepatitis; Hepatitis C; Hepatitis C - complications; Hepatitis C - drug therapy; Hepatology; HIV; HIV Infections - complications; Human immunodeficiency virus; Humans; Immunosuppression; Interferon; Liver cirrhosis; Liver Cirrhosis - complications; Liver diseases; Lymphocytes T; Male; Middle Aged; Motivation; Original; Patients; Registries; Ribavirin; Ribonucleic acid; Ritonavir; RNA; RNA viruses; Sex ratio; Treatment Failure